Strategy

Feb 01, 2013
Pharmaceutical Executive
"Drug Life Optimization" can wrest more value through strategies that build a drug's brand franchise through its entire lifespan, according to Stan Bernard.
Jan 01, 2013
Pharmaceutical Executive
New research sheds fresh light on a trend with serious consequences for the public health—not only in the United States but for patients worldwide.
Nov 01, 2012
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Chinese start-ups have realized that they need to recruit highly skilled and globally oriented general managers from foreign multinationals when they reach a critical size.
Nov 01, 2012
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Unified payer research planning is of top import.
Oct 04, 2012
By Pharmaceutical Executive Editors
Oct 01, 2012
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Pharmaceutical companies looking to wrest market share in high growth markets of tomorrow must overcome challenges from a new crop of national champions.
Oct 01, 2012
Pharmaceutical Executive
Pharm Exec takes a look at how a mid tier player — Denmark's Lundbeck — is counting on the momentum of the big US market to vault it to global leadership position.
Sep 01, 2012
Pharmaceutical Executive
High priced biologics may have a bright future in emerging markets, but winning access in the short term will be a hard sell.
Sep 01, 2012
Pharmaceutical Executive
Shareholder value now depends on finding pockets of "good" growth, in segments with fewer players, and where expenses can be tightly controlled.
Aug 29, 2012
By Pharmaceutical Executive Editors
world to improve the real world. The group brings value to over 150,000 customers of all sizes, in all industries, in more than 80 countries. For more information, visit www.3ds.com.
native1_300x100
lorem ipsum